Correspondence
Contact Sovereign Peptides
A specific correction is welcome, particularly when two similar molecule names have become tangled.
Corrections
I can do something useful with a message that points to a page, quotes the disputed passage and names the study that contradicts it. A DOI or PubMed identifier makes the relevant paper easier to locate. Corrections to the molecule, study population, endpoint or regulatory wording are especially valuable.
Editorial correspondence: editors@sovereignpeptides.com.
Please include enough of the source passage to show the problem. A disagreement about interpretation is welcome too, provided the measurement and the interpretation can be distinguished. A reply has no guaranteed timetable.
Medical requests
This mailbox cannot assess symptoms, suggest a dose or arrange treatment. It also cannot help source compounds. Personal medical information is unnecessary for correcting an article; a clinician responsible for a person's care is the appropriate recipient for a health history.
The about page explains the purpose of Sovereign Peptides. The reading list may help identify the paper behind a passage before writing.